The Sixth Circuit on Wednesday declined to revive an Ohio State University oncology researcher's defamation suit against The New York Times, finding that an article the newspaper published about him containing allegations of scientific misconduct wasn't defamatory.
Several Republican senators took the rare step of sharply criticizing another one of President Donald Trump’s judicial nominees during a hearing Wednesday, taking particular issue with his past ruling in support of Obamacare's mandated coverage of contraception.
Medical Properties Trust Inc. on Wednesday said a follow-on stock offering brought in more than $850 million, which the Goodwin Procter-led real estate investment trust plans to use toward the acquisition of more than a dozen U.S. health care facilities.
A group of ex-21st Century Oncology doctors embroiled in a dispute with the bankrupt cancer treatment chain is asking a New York bankruptcy court to reject the company's proposed adversary action against them.
A helicopter ambulance provider has agreed to pony up $3 million to settle a suit brought on behalf of more than 400 current and former employees who claim the company flouted Kentucky law by not properly paying them overtime.
A Rhode Island federal judge agreed to certify a class of Loestrin purchasers suing Warner Chilcott and Watson Pharmaceuticals for nearly $2 billion for allegedly sidelining generic alternatives to the widely used birth control drug.
Attorneys at a small Pittsburgh law firm should honor their word and can be jointly held to an oral agreement to split the fees from a $4.25 million medical malpractice settlement, a Pennsylvania state court judge said Wednesday in overruling their efforts to toss the case.
A Florida federal judge on Wednesday set a September sentencing date for Miami nursing home mogul Philip Esformes, who was convicted on charges of kickbacks, money laundering, bribery and obstruction of justice related to an alleged $450 million health care fraud scheme.
A surgeon who specializes in removing pelvic mesh devices told a California judge Tuesday that women's bodies reject the devices leading to lifelong pain and other complications, during the first full day of testimony in the bench trial on state Attorney General Xavier Becerra's claims that Johnson & Johnson falsely marketed its mesh.
A landscaping company that was responsible for ice removal outside an Illinois medical center reached an $800,000 settlement in state court with a doctor who was injured in a fall on a slippery sidewalk, according to lawyers involved in the case.
A Pennsylvania appellate court said Tuesday that the widow of a man who died from a leg amputation should get a new trial because the lower court mistakenly allowed two jurors who admitted bias against medical malpractice plaintiffs.
Justice John Paul Stevens wrote over 1,000 opinions in his 34 years on the U.S. Supreme Court, leaving a footprint in the court’s jurisprudence still visible today. Here, Law360 looks back at his most important decisions, from landmark First Amendment cases to those involving the separation of powers.
His critics called him a "liberal activist." His fans? A "liberal icon." But those who worked for Justice John Paul Stevens remember a common law judge who took things one case at a time.
The U.S. Government Accountability Office has denied a pharmaceutical company's protest over a U.S. Department of Veterans Affairs contract to provide erectile dysfunction medication, saying that the agency reasonably nixed the solicitation over the firm's high-priced bid.
A trio of Yale University workers sued the school in Connecticut federal court Tuesday over its employee wellness program’s $1,300 per year fine for nonparticipants, saying the penalty places the program in violation of the Americans with Disabilities Act and the Genetic Information Nondiscrimination Act.
Retired Justice John Paul Stevens, a World War II veteran who became a liberal icon during his more than three decades on the U.S. Supreme Court, died Tuesday at 99, the Supreme Court said.
Center City Healthcare LLC, the bankrupt owner of two medical facilities in Philadelphia, submitted bidding procedures Tuesday in Delaware governing the proposed Chapter 11 sale of St. Christopher’s Hospital for Children with a transaction closing deadline in early October.
An Illinois risk fund’s lawsuit seeking to hold more than 30 parties liable over the nation’s opioid crisis belongs in state court because it does not involve significant questions of federal law, a Chicago federal judge said Monday.
Drexel University has accused its insurer of reneging on an obligation to provide defense coverage for a string of lawsuits against the school over a former high-ranking university doctor who pled guilty to sexually abusing patients.
Florida's First District Court of Appeal appeared during oral arguments Tuesday to lean toward letting the state House of Representatives enter a case in which a lower court found that regulations it established for medical marijuana treatment centers are unconstitutional.
Loestrin end payors on Monday moved for preliminary approval of their $1 million settlement with Lupin Pharmaceuticals to resolve their portion of litigation accusing the company of working with another pharmaceutical duo to sideline generic alternatives to the widely used birth control drug.
Prime US REIT is reportedly paying $1.2 billion for a portfolio of U.S. properties, Muss Development is said to have leased out 42,982 square feet in New York to EmblemHealth, and InvenTrust has reportedly picked up a Florida shopping center from Blackstone for $97 million.
A special purpose acquisition company focused on buying a cannabis-related business closed a $575 million initial public offering in Canada on Tuesday in what is said to be the largest IPO from a blank-check vehicle in Canadian history.
The New Jersey appeals court on Tuesday revived civil conspiracy and unfair competition claims by charity hospital Deborah Heart and Lung Center against Virtua Health and a physician's group, ruling a jury should determine whether a conspiracy to steer cardiac patients away from Deborah existed.
The Ohio federal judge overseeing multidistrict litigation over the opioid crisis said that national data on opioid sales before December 2012 should be publicly available.
In the final installment of this monthly series, legal recruiting expert Carlos Pauling from Major Lindsey & Africa talks with Virginia Essandoh about the trends and challenges she sees as chief diversity officer at Ballard Spahr.
In "Theodore Roosevelt for the Defense," authors Dan Abrams and David Fisher meticulously chronicle the forgotten high-profile 1915 libel trial of Teddy Roosevelt, capturing the interesting legal customs of an era before things like notice pleading and pretrial discovery, says Chief U.S. District Judge Colleen McMahon of the Southern District of New York.
PDR Network v. Carlton & Harris is a Telephone Consumer Protection Act case, but the U.S. Supreme Court's decision last week drew some important battle lines over the broader question of agency deference, say Artin Betpera and David Carter of Womble Bond.
Though occupational licensing regulations and scope-of-practice laws help to maintain health care quality, they may also increase barriers to entry, which reduces competition and exacerbates provider shortages and rising health care costs, say experts at Analysis Group.
The contours of the Texas Supreme Court's decision in Rohrmoos Venture v. UTSW DVA Healthcare provide important clarifications, reminders and cautions regarding attorney fee claims — most importantly, that providing billing records is essentially indispensable, say attorneys at Jones Walker.
The U.S. Tax Court’s recent determination in Romano-Murphy v. Commissioner, that failure to provide a preassessment hearing invalidated IRS penalties, highlights important distinctions between key functions and personnel within the IRS Office of Appeals, say Michael Chittenden and Michael Lloyd at Covington.
The U.S. Department of Justice recently reiterated that it will not tolerate government contractors that lack a required business and ethics compliance program. With consequences so high, now is the time for companies that have fallen behind to catch up, say Robert Tompkins and Rodney Perry at Holland & Knight.
Nevada’s recently enacted Senate Bill 220 gives state residents a broad right to opt out of the sale of their personal information. Companies currently preparing for the California Consumer Privacy Act cannot assume that CCPA compliance equates to compliance with S.B. 220, say Sadia Mirza and Yanni Lin at Troutman Sanders.
Businesses providing services over the internet are likely to face continued challenges to comply with the expanding implementation of China's cybersecurity law, especially with respect to broadening definitions of personal information holders under new guidance, say Xiaoyan Zhang and Vincent James Barbuto of Reed Smith.
North Dakota's consumer fraud and public nuisance claims against opioid manufacturer Purdue Pharma were recently dismissed by a state court. The decision provides a framework for opioid defendants to challenge similar allegations in other jurisdictions, and may prove timely for Johnson & Johnson in its current Oklahoma trial, says Cameron Turner of Segal McCambridge.
Contractors that do business with federal, state and local government entities face an interesting — and intensifying — predicament: How to develop a comprehensive yet straightforward compliance program that satisfies varying laws in varying jurisdictions, say Jeniffer Roberts and Katherine Veeder at Alston & Bird.
When evaluating potential new hires, law firms should utilize structured interviews in order to create a consistent rating system that accurately and effectively assesses candidates' skills and competencies, says Jennifer Henderson of Major Lindsey.
Though multiple worker classification questions still swirl around the California Supreme Court's Dynamex decision, many have wondered what it means for white collar independent contractors. The law is still murky on this point, but there are several steps that might help hiring companies rebut a misclassification claim, say Raymond Bertrand and James de Haan at Paul Hastings.
Reducing the soaring costs of commonly used prescription drugs has become a political priority in the nation’s statehouses. But thus far, states have done better at increasing transparency around drug pricing than at actually lowering prices, says Lou Cannon of State Net Capitol Journal.
A primary benefit of the virtual law team in mass tort litigation is creative collaboration. A "company case" approach is essential to breaking down the silos between team members, say attorneys at FaegreBD and Reed Smith.